Drug intelligence / Profile preview

astragalus membranaceus saponins

Development stage
Preclinical
Modality
Small Molecules, Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

Astragalus membranaceus saponins are a group of triterpenoid glycosides (saponins) extracted from the root of Astragalus membranaceus, a plant widely used in traditional Chinese medicine. The main active constituents include various astragalosides (notably astragaloside IV), which have been shown to possess immunomodulatory, antioxidant, anti-inflammatory, and anticancer properties[2][3][4][8]. Mechanistically, these saponins modulate multiple cellular pathways including inhibition of tumor cell proliferation and migration; induction of apoptosis via caspase 3 activation; cell cycle arrest at S and G2/M phases; suppression of cyclin-dependent kinase activity; regulation of the NOX4/Nrf2 signaling pathway (notably in neuroprotection/ferroptosis); modulation of Wnt/beta-catenin and Notch1/hes1 signaling pathways for osteogenic and cardioprotective effects; downregulation of VEGF for anti-angiogenesis; enhancement of immune responses through activation or regulation of toll-like receptor 4-related MAPK activities[4][5][6][8]. These compounds are under investigation for their potential use as adjuvant therapies in cancer treatment (especially gastrointestinal cancers), neurodegenerative diseases such as Alzheimer’s disease, diabetes mellitus type 2, inflammatory conditions like colitis, and as general immunostimulants[1][5][6].

Other names
astragalus saponinsASTastragalosides
02

Targets

NOX4 (NADPH oxidase 4)CASP3 (Caspase-3)TLR4 (Toll-like receptor 4)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NOTCH (Neurogenic locus notch homolog protein 3)CDK (CDK family)

Beyond the preview

Go deeper on astragalus membranaceus saponins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on astragalus membranaceus saponins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call